Orchid Chemicals & Pharmaceuticals

Orchid Chemicals inks antibiotics development pact with Europe’s Allecra Therapeutics

18 Apr 2013

Orchid sells API, R&D unit to Hospira for Rs1,113 crore to reduce debt

30 Aug 2012

The businesses sold accounted for around 23 per cent of the total sales of the company last year

Orchid shuts Alathur plant on pollution concerns

12 Jul 2011

Orchid Chemicals to take over US-based Karalex Pharma

10 Jun 2010

Orchid in out-licensing deal with Alvogen for oral non-antibiotic for US sales

05 May 2010

Orchid also settles Namenda patent issues with Forest Labs

29 Apr 2010

Orchid receives tentative FDA approval for Alzheimer’s drug Memantine tablet

08 Jan 2010

Hospira of US buys Orchid’s injectables business

16 Dec 2009

Orchid has 54 products for launch in the US, has also filed about 72 marketing applications to supply active pharmaceutical ingredients.

Orchid receives USFDA approval for Zaleplon capsules

18 Sep 2009

Orchid Chem gets US nod to sell generic antibiotic

16 Sep 2009

Orchid receives EU approvals for anti-bacterial injections Piperacillin, Tazobactam

04 Aug 2008

US FDA approval Orchid's ANDA for Cefpodoxime Proxetil

17 Nov 2007

Orchid's formulation and API facilities approved by UK MHRA

21 Sep 2006

Higher investments, rural affluence results in exponential corporate growth

23 Mar 2006

Orchid Chemicals' fire victims were insured: K Raghavendra Rao

08 Nov 2005

Orchid Chemicals strengthens finances with GDR and FCCB issue

31 Oct 2005

1: 2 bonus from Orchid Chemicals

18 Jul 2005

Orchid in deal with Stada for generic drug products

17 Mar 2005

Orchid in tie up with Par Pharmaceuticals Inc. to market oral cephalosporin in the US

28 May 2004

Orchid's US discovery JV successful

22 May 2004

Orchid files ANDA for Cefazolin finished dosage form

15 May 2004

Orchid Pharma soon to file ANDA from its new plant

13 Apr 2004

Orchid Pharma soon to file ANDA from its new plant

02 Apr 2004

Orchid granted Certificate of Suitability for Cefadroxil Monohydrate

30 Mar 2004

One more CoS for Orchid Chemicals

19 Feb 2004